The famed income investor Neil Woodford has put almost 8% of his flagship funds money into one company, AstraZeneca (LSE: AZN). Here are five reasons why hes so confident that this investment will work out for him and his investors.
Our top analysts have highlightedfive top shares in theFTSE 100in our special free report “5 Shares To Retire On“. To find out the names of the shares and the reasons behind their inclusion, simplyclick hereto view it immediately with no obligations whatsoever.
Owain Bennallackowns shares in AstraZeneca. The Motley Fool UK has no position in any of the shares mentioned. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.